Paper Details 
Original Abstract of the Article :
Introduction In most of the oral surgical procedures performed under local anesthesia, we often face a great difficulty while performing surgeries because of reduced accessibility and visibility which is hampered by blood and saliva at the surgical site. Anticholinergic drugs like atropine sulphate ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779147/

データ提供:米国国立医学図書館(NLM)

Effect of Intramuscular Atropine Sulphate and Glycopyrrolate on Heart Rate and Salivary Secretion in Patients Undergoing Minor Oral Surgical Procedure

The world of [oral surgery] presents a unique set of challenges, including the need to control saliva flow during procedures. This study investigates the effectiveness of two commonly used anticholinergic drugs, atropine sulphate and glycopyrrolate, in reducing salivary secretion during minor oral surgical procedures.

Comparing Atropine Sulphate and Glycopyrrolate

The researchers conducted a [randomized controlled trial] comparing the effects of intramuscular atropine sulphate and glycopyrrolate on salivary secretion and heart rate in patients undergoing minor oral surgical procedures. The study found that both drugs were equally effective in reducing salivary secretion. However, atropine sulphate was associated with a significant increase in heart rate, while glycopyrrolate did not cause any significant changes in heart rate.

Clinical Implications

The study's findings suggest that [glycopyrrolate] may be a safer option than atropine sulphate for reducing salivary secretion during minor oral surgical procedures under local anesthesia. Clinicians should carefully consider the potential for cardiac side effects when choosing between these two drugs, prioritizing the safety and well-being of their patients.

Dr. Camel's Conclusion

This study offers valuable insights into the [pharmacological effects] of atropine sulphate and glycopyrrolate in reducing salivary secretion during oral surgical procedures. The researchers' careful comparison of the two drugs reveals that glycopyrrolate may be a safer option due to its lack of significant cardiac side effects. This knowledge is crucial for clinicians to make informed decisions about medication choices, ensuring the optimal care of their patients. As Dr. Camel, I am always impressed by the meticulousness of medical research and the dedication of researchers to finding safer and more effective treatments. This study serves as a reminder of the importance of careful consideration of drug interactions and side effects, even for seemingly simple procedures.
Date :
  1. Date Completed n.d.
  2. Date Revised 2021-01-11
Further Info :

Pubmed ID

33409027

DOI: Digital Object Identifier

PMC7779147

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.